It’s an audacious mission—a quest to radically change the course of medicine. We’re aligning our investments in scientific research, manufacturing and most of all, people, to change the way cancer and other serious diseases are treated.
Learn MoreOur investigational technology programs T cells to recognize and attack cancer cells. It’s a revolutionary approach for the treatment of cancer and other serious diseases.
Learn about CAR and TCR technologies
We have multiple product candidates in development for a variety of cancers, including Non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL).
See an in-depth view of our current pipeline
If you’re interested in a career that pushes the bounds of what is possible and work that has the potential to revolutionize medicine, then we would like to hear from you.
View open positions and learn about life at Juno
Everything Juno Therapeutics
@JunoThera
Juno’s Sunil Agarwal writes for @Forbes: CAR T therapy is here to stay. https://t.co/SJmDOStGNA Impt. info: https://t.co/MdDuth5GOU
